Vimarsana
Biggest News Aggregation in the World

Benjamin Bakall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Benjamin Bakall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Benjamin Bakall Today - Breaking & Trending Today

Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024 - Vimarsana News

Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data Presentation at Retinal Cell and Gene Therapy Innovation Summit 2024

Published: April 29, 2024

MALVERN, Pa., April 29, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today announced that...

Source: marketscreener.com
Related Topics:
United StatesUniversity Of ArizonaBenjamin BakallOcugen IncExchange CommissionClinical Research At Associated Retina ConsultantsHead Of CommunicationsOregon HealthNuclear Hormone ReceptorCollege Of MedicineScience University Casey Eye InstituteFoundation Fighting BlindnessClinical ResearchAssociated Retina ConsultantsClinical Assistant ProfessorRetinal CellGene Therapy Innovation SummitScience University Casey EyeHormone Receptor Based Gene Modifier TherapyHyatt RegencyPrivate Securities Litigation Reform Act
Ocugen Announces OCU400—Modifier Gene Therapy - Vimarsana News

Ocugen Announces OCU400—Modifier Gene Therapy

Published: April 29, 2024

MALVERN, Pa., April 29, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) OCGN, a biotechnology company focused on discovering, developing, and…

Source: biztoc.com
Related Topics:
Benjamin BakallClinical Research At Associated Retina ConsultantsOcugen IncClinical ResearchAssociated Retina ConsultantsClinical Assistant ProfessorReaking News
Ocugen to Present on Modifier Gene Therapy Platform at - Vimarsana News

Ocugen to Present on Modifier Gene Therapy Platform at

Published: April 26, 2024

MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering,...

Source: globenewswire.com
Related Topics:
Nieraj JainTarun UpadhyayJoses PulidoMurthy ChavaliShankar MusunuriBorooah ShyamangaBenjamin BakallArunk UpadhyayNalin MehtaSahar MatloobPaul YangUniversity Of MiamiOcugen IncHead Of Research DevelopmentSeattle Convention CenterNuclear Hormone ReceptorExchange CommissionHead Of CommunicationsAssociation For ResearchClinical DevelopmentHormone Receptor Based Gene Modifier TherapyRetinitis Pigmentosa AssociatedByron LamEndowed ChairMarch Building
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting - Vimarsana News

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

Published: April 26, 2024

MALVERN, Pa., April 26, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...

Source: marketscreener.com
Related Topics:
Shankar MusunuriMurthy ChavaliBenjamin BakallBorooah ShyamangaArunk UpadhyayPaul YangNalin MehtaSahar MatloobTarun UpadhyayNieraj JainJoses PulidoUniversity Of MiamiOcugen IncHead Of Research DevelopmentSeattle Convention CenterNuclear Hormone ReceptorHead Of CommunicationsExchange CommissionAssociation For ResearchClinical DevelopmentHormone Receptor Based Gene Modifier TherapyRetinitis Pigmentosa AssociatedByron LamEndowed ChairMarch Building
UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting - Vimarsana News

UPDATE -- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

Published: April 26, 2024

MALVERN, Pa., April 26, 2024 -- Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the...

Source: marketscreener.com
Related Topics:
Murthy ChavaliBenjamin BakallTarun UpadhyayJoses PulidoBorooah ShyamangaArunk UpadhyaySahar MatloobShankar MusunuriPaul YangNieraj JainNalin MehtaExchange CommissionClinical DevelopmentOcugen IncNuclear Hormone ReceptorHead Of Research DevelopmentAssociation For ResearchUniversity Of MiamiSeattle Convention CenterHead Of CommunicationsHormone Receptor Based Gene Modifier TherapyRetinitis Pigmentosa AssociatedByron LamEndowed ChairMarch Building